Summary
- A New Jersey federal judge has dismissed a whistleblower suit from a former Eli Lilly sales manager, who claimed she was fired for opposing off-label promotion of the diabetes drug Mounjaro.
- The court found it lacked personal jurisdiction over Eli Lilly, which is based in Indiana.
- This ruling underscores the challenges whistleblowers face in establishing jurisdiction against large corporations.
- Legal experts suggest this decision may impact similar claims in the pharmaceutical industry moving forward.
Join the discussion — sign up to comment, upvote, and save articles.